1. 河南中医药大学第一附属医院
2. 河南省南阳市中医院
3. 北京中医药大学东方医院
4. 河南省漯河市中医院
5. 陕西省中医医院
6. 河南省安阳市人民医院
7. 陕西中医药大学第二附属医院
8. 中国中药协会药物研究评价技术中心
9. 贵州医科大学第二附属医院
10. 北京康派特医药科技开发有限公司
11. 石河子大学医学院第一附属医院
12. 河北工程大学附属医院
13. 湖北省鄂州市中心医院
14. 河北省邯郸市中医院
15. 山东省枣庄市妇幼保健院
纸质出版:2021
移动端阅览
[1]闫永彬,丁樱,郑海涛,吴力群,谢晓丽,韩选明,罗红芳,谷强,赖维阳,邵荣昌,李学明,张乐元,全惜春,冯自威,丁学星,高学敏,李磊,李丽琦.参苓健脾胃颗粒治疗小儿腹泻病(脾虚泻)119例多中心随机对照双盲临床研究[J].中医杂志,2021,62(08):677-682.
YAN Yongbin, DING Ying, ZHENG Haitao, et al. Shenling Jianpiwei Granules (参苓健脾胃颗粒) in Treating 119 Cases of Children’s Diarrhea with Spleen Deficiency Pattern: a Multi-center,Randomized,Double-blind Placebo-controlled Trial[J]. Journal of Traditional Chinese Medicine2021, 62(8): 677-682.
[1]闫永彬,丁樱,郑海涛,吴力群,谢晓丽,韩选明,罗红芳,谷强,赖维阳,邵荣昌,李学明,张乐元,全惜春,冯自威,丁学星,高学敏,李磊,李丽琦.参苓健脾胃颗粒治疗小儿腹泻病(脾虚泻)119例多中心随机对照双盲临床研究[J].中医杂志,2021,62(08):677-682. DOI: 10.13288/j.11-2166/r.2021.08.008.
YAN Yongbin, DING Ying, ZHENG Haitao, et al. Shenling Jianpiwei Granules (参苓健脾胃颗粒) in Treating 119 Cases of Children’s Diarrhea with Spleen Deficiency Pattern: a Multi-center,Randomized,Double-blind Placebo-controlled Trial[J]. Journal of Traditional Chinese Medicine2021, 62(8): 677-682. DOI: 10.13288/j.11-2166/r.2021.08.008.
目的评价参苓健脾胃颗粒治疗小儿腹泻病(脾虚泻)的临床疗效及安全性。方法采用随机、双盲、阳性药平行对照、多中心临床试验方法
将238例患儿分为治疗组和对照组各119例
治疗组口服参苓健脾胃颗粒(每袋10g
201~<3岁
每次1/3袋
每日3次;3~<5岁
每次0.5袋
每日3次;5~<7岁
每次1袋
每日2次)及儿宝颗粒模拟剂(每袋5g
201~<4岁
每次1袋
每日2次;4~<7岁
每次1.5袋
每日2次)
对照组口服参苓健脾胃颗粒模拟剂(用法用量同参苓健脾胃颗粒)及儿宝颗粒(用法用量同儿宝颗粒模拟剂)
两组疗程均为10天
疗程中临床痊愈者随时停药
按完成病例处理。比较两组患儿大便复常率、止泻时间、疾病总有效率以及中医证候疗效与安全性。结果治疗组患儿在全分析集(FAS)、符合方案分析集(PPS)中大便复常率分别为81.20%、86.11%
对照组分别为82.76%、83.96%
治疗组-对照组差值95%置信区间(-0.1143
0.0831)
两组疗效相当。中位止泻时间两组均为6.00天。治疗组疾病总有效率在FAS、PPS中分别为99.09%、99.07%
对照组分别为98.23%、98.11%
组间比较差异无统计学意义(P>0.05)。治疗组中医证候痊愈率在FAS、PPS中
分别为62.73%、62.96%
对照组分别为61.06%、62.26%
组间比较差异无统计学意义(P>0.05)。结论参苓健脾胃颗粒治疗小儿腹泻病(脾虚泻)疗效确切
与儿宝颗粒疗效相当
且安全性较好。
Objective To evaluate the efficacy and safety of Shenling Jianpiwei Granules(SJG
参苓健脾胃颗粒) in treating children′s diarrhea with spleen deficiency pattern. Methods A multi-center
randomized
double-blind
double-dummy
positive drug parallel controlled trial was designed
where 238 patients were divided into treatment group and control group with 119 cases in each group. The treatment group took SJG(10 g per packet; 1/3 packet for 3 times daily if the age was ≥1 and <3 years old; 1/2 packet for 3 times daily if the age was ≥3 and <5 years old; 1 packet for twice daily if the age was ≥5 and <7 years old) plus Erbao Granules(儿宝颗粒) placebo(5 g per packet; 1 packet for twice daily if the age was ≥1 and <4 years old; 1.5 packet for twice daily if the age was ≥4 and <7 years old); the control group took SJG placebo and Erbao Granules
and the usage and dosage were the same as those of treatment group. Both groups were treated for 10 days. Patients should stop taking the drug when they were clinically cured during the treatment
and were considered as completed cases. The rate of bowel movement returning to normal
diarrhea duration
total effectiveness rate
traditional Chinese medicine(TCM) symptoms improvement
and safety were assessed and compared between the two groups. Results The full analysis set(FAS) and per-protocol set(PPS) analyses showed that the rate of bowel movement returning to normal in the treatment group was 81.20% and 86.11%
respectively
while that of control group was 82.76% and 83.96%
respectively; the comparison between groups were not significantly different as 95% confidence interval was-0.1143 to 0.0831. The median diarrhea duration was 6 days in both groups. The FAS and PPS results of total effectiveness rate were 99.09% and 99.07% in the treatment group and 98.23% and 98.11% in the control group
with no significantly statistical differences between groups(P>0.05). The FAS and PPS results of TCM symptoms improvement rate were 62.73% and 62.96% in the treatment group while those were 61.06% and 62.26% in the control group
showing no significant differences between groups(P>0.05). Conclusion SJG is effective in treating children′s diarrhea with spleen deficiency pattern
showing the similar effect with Erbao Granules
and is safe.
0
浏览量
63
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010102007558号